User menu

Galaxy-2 trial: A randomized phase 3 study of ganetespid in combination with docetaxel versus docetaxel alone in patients with advanced non-small cell lung adenocarcinoma

Bibliographic reference Pieters, Thierry. Galaxy-2 trial: A randomized phase 3 study of ganetespid in combination with docetaxel versus docetaxel alone in patients with advanced non-small cell lung adenocarcinoma.ASCO Annual meeting 2014 (Chicago, du 31/05/2014 au 04/06/2014).
Permanent URL http://hdl.handle.net/2078.1/150789